Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Daniel Adams
AddedMar 31, 2024
UpdatedMay 1, 2026
Daniel Adams

Daniel Adams

Board Member, NextWaveBio

Daniel Adams's Career

NextWaveBio
NextWaveBio

East Hartford, CT, US

Board Member· Board
EpiVax Oncology
EpiVax Oncology

Providence, RI, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Daniel Adams's Career

NextWaveBio
NextWaveBio
Investment FirmInvestment Firm22018East Hartford, CT, US
Board Member· Board

Leadership at NextWaveBio

Manon CoxManon CoxCo-Founder

Similar to NextWaveBio

Hibiscus BioVenturesHibiscus BioVenturesRockville, MD, USest. 2019Hibiscus BioVenturesRockville, MD, US · est. 2019

Pharmaceutical consultancy dedicated to advancing patient care through viable therapeutics and diagnostics.

Investment Firm11
BiocapxBiocapxNew York City, NY, USest. 2016BiocapxNew York City, NY, US · est. 2016

Tech-enabled platform offering easy access to curated, institutional-grade biotech investments.

Investment Firm · $750k1
MedVenture AssociatesMedVenture AssociatesEmeryville, CA, USest. 1986MedVenture AssociatesEmeryville, CA, US · est. 1986

Medical tech investment firm, funding next-gen healthcare innovations and their creators.

Investment Firm30
Acorn BioventuresAcorn BioventuresNew York City, NY, USest. 2017Acorn BioventuresNew York City, NY, US · est. 2017

Private investment provider in biotech, specialty pharma, and medical devices.

Investment Firm5
EpiVax Oncology
EpiVax Oncology
Pre-Seed$1.5M52017Providence, RI, US
Board Member· Board

Leadership at EpiVax Oncology

Annie De GrootAnnie De GrootCo-Founder & CEO
William MartinWilliam MartinCo-Founder
Gad BerdugoGad BerdugoCo-Founder

Similar to EpiVax Oncology

EpivaxEpivaxProvidence, RI, USVaccine Designest. 1998EpivaxProvidence, RI, US · est. 1998

EpiVax, a US-based immunology company, excels in computational immunology analysis.

Seed · $6.6M15
CancervaxCancervaxSanta Barbara, CA, USCancer Treatmentest. 2021CancervaxSanta Barbara, CA, US · est. 2021

CancerVAX Biotech: Santa Barbara-based medical firm innovating universal cancer treatments.

Seed · $500k13
AgilvaxAgilvaxAlbuquerque, NM, USImmunotherapies, Vaccinesest. 2011AgilvaxAlbuquerque, NM, US · est. 2011

Agilvax Inc: A biotech firm specializing in developing immunotherapies for cancer and targeted vaccines.

Series A · $8.3M11
OncoPrecisionOncoPrecisionNew York City, NY, USCancer Treatmentest. 2020OncoPrecisionNew York City, NY, US · est. 2020

Developing advanced tech for personalized cancer treatment and aiding in transformative therapy creation.

Seed · $4.2M37

Daniel Adams's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Daniel Adams

Chris ViehbacherChris ViehbacherBoard Member · Before BrandsKasper LageKasper LageBoard Member · BiogenCaroline DorsaCaroline DorsaBoard Member · BiogenDaniel LevittDaniel LevittCo-Founder · BiozDaniel Abdun-NabiDaniel Abdun-NabiBoard Member · RegenxbioRisusdanRisusdanBoard Member · BG Medicine